Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PXMD PaxMedica > Detailed Quotes

PXMD PaxMedica

Watchlist
2.260
-0.140-5.83%
Close 10/03 16:00 ET
2.200
-0.06-2.65%
Pre Mkt Price 10/04 05:41 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
2.441
Open
2.430
Turnover
479.25K
Low
2.200
Pre Close
2.400
Volume
206.96K
Market Cap
26.62M
P/E(TTM)
5.32
52wk High
10.480
Shares
11.78M
P/E(Static)
Loss
52wk Low
2.040
Float Cap
3.49M
Bid/Ask %
-62.50%
Historical High
10.480
Shs Float
1.55M
Volume Ratio
0.07
Historical Low
2.040
Dividend TTM
--
Div Yield TTM
--
P/B
-3.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
13.39%
Amplitude
10.04%
Avg Price
2.315
Lot Size
1
Float Cap
3.49M
Bid/Ask %
-62.50%
Historical High
10.480
Shs Float
1.55M
Volume Ratio
0.07
Historical Low
2.040
Dividend TTM
--
P/B
-3.37
Dividend LFY
--
Turnover Ratio
13.39%
Amplitude
10.04%
Avg Price
2.315
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company’s lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top